
AVBP
ArriVent BioPharma Inc.
$20.35
+$0.29(+1.45%)
57
Overall
60
Value
54
Tech
--
Quality
Market Cap
$738.11M
Volume
164.69K
52W Range
$15.47 - $30.41
Target Price
$39.22
Company Overview
| Mkt Cap | $738.11M | Price | $20.35 |
| Volume | 164.69K | Change | +1.45% |
| P/E Ratio | -9.2 | Open | $19.88 |
| Revenue | -- | Prev Close | $20.06 |
| Net Income | $-80.5M | 52W Range | $15.47 - $30.41 |
| Div Yield | N/A | Target | $39.22 |
| Overall | 57 | Value | 60 |
| Quality | -- | Technical | 54 |
No chart data available
Latest News
H.C. Wainwright Keeps Their Buy Rating on ArriVent BioPharma, Inc. (AVBP)
TipRanks Auto-Generated Intelligence Newsdesk•13 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVBP | $20.35 | +1.4% | 164.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |